| Revenue growth | 18% YoY for Q4FY26 (Aster India) |
|---|---|
| Margins | Operating EBITDA margins improved to 20.7% for Aster India |
| Demand visibility | High, driven by 12% YoY patient volume growth |
| Management confidence | Strong due to shareholder approval of QCIL merger |
Growth
Q4FY26 Aster India revenue grew 18%, EBITDA grew 26% to ₹244 Cr. Combined entity FY26 revenue reached ₹9,273 Cr, up 14%.
Outlook
Merger completion targeted for Q1FY27. Planned addition of 4,445 beds to reach 15,068 total capacity by FY30.
Risks
Minor impact noted from Nurses' Strike in Kerala; macro headwinds cited affecting Labs and Pharmacy segments.
Earnings Call filed with NSE, NSE: ASTERDM. Summary written with AI assistance from the document.
Aster DM Quality Care Ltd: key numbers
- Share price
- ₹725.10
- Market cap
- ₹63,205 Cr
- Revenue (annual)
- ₹4,643 Cr
- Net profit (annual)
- ₹388.1 Cr
- P/E (TTM)
- 134.3×Sector 54.5×
- Promoter holding
- 53.79%+13.40% QoQ
- FII holding
- 12.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aster DM Quality Care Ltd
All →Aster DM Quality Care Adverse Business Impact
Aster DM Quality Care terminated its O&M and Medical Services agreements with DM Education and Research Foundation, ceasing related hospital operations. The Aster Wayanad hospital contributed 1.20% of turnover; no consideration was received.
Aster DM Quality Care Acquisition Worth ₹102.5 Cr
Aster DM will acquire Sri Sainatha Hospitals by converting a Rs 102.46 Crore loan into equity. The related-party deal completes within three months.
- Value
- ₹102.5 Cr
- Execution
- Within 3 months
Aster DM Quality Care Capital Structure Change
Aster DM approved converting a Rs 102.46 Crore subsidiary loan into equity shares. It also approved terminating DMERF operations and medical services agreements.
- Value
- ₹102.5 Cr
- Execution
- Within 3 months
Aster DM Quality Care Results Update
Aster DM Quality Care released a press release on its Q2 FY27 unaudited results, reporting revenue up 19% to Rs 2,829 crore. Normalised PAT rose 34% to Rs 281 crore.
Aster DM Quality Care Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 2,829 Cr (+19% YoY), Op EBITDA INR 678 Cr (+25%), margin 24.0% (+111 bps), normalised PAT INR 281 Cr (+34%). Post-merger synergies and bed expansion to 15,070.
Aster DM Quality Care Q2 FY27 Results: Net Profit ₹322.4 Cr, Up 165.8% YoY
Aster DM Quality Care Ltd reported revenue from operations of ₹2,829 Cr (+136.3% YoY) and net profit of ₹322.4 Cr (+165.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹322.4 Cr · +165.8% YoY